Latest revenue
—
as of —
Latest net income
—
as of —
Net margin
—
as of —
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $481.5M
- Enterprise value
- $481.5M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $6.15
- 52-wk low
- $2.00
- Beta
- —
- Shares out
- 102.7M
5-year trend
About ACHV
Business description and risk factors will appear here once ACHV's latest filing is fully ingested.
Profitability
Return on equity
-261.5%
37.2%Return on assets
-130.8%
26.8%Leverage
Debt / equity
1.00×
17.8%Debt / assets
50.0%
8.9%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | — | — | $-10.2M | +20.7% | — |
Q4 2025 2025-12-31 | — | — | $-14.7M | -18.6% | — |
Q3 2025 2025-09-30 | — | — | $-14.4M | -15.4% | — |
Q2 2025 2025-06-30 | — | — | $-12.7M | -50.3% | — |
Q1 2025 2025-03-31 | — | — | $-12.8M | -97.5% | — |
Q4 2024 2024-12-31 | — | — | $-12.4M | — | — |
Q3 2024 2024-09-30 | — | — | $-12.5M | -76.0% | — |
Q2 2024 2024-06-30 | — | — | $-8.5M | -2.7% | — |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
In Vitro & In Vivo Diagnostic Substances · SIC 2835
Your notes
Keep private notes on ACHV — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$1.1M
Net activity
−$1.1M
Distinct insiders
6
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns ACHV
Institutional value
$32.4M
Total shares held
11.0M
Distinct holders
40
-37 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | FRANKLIN RESOURCES INC | 4.4M | $12.8M | +0 (+0.0%) | No change |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 2.2M | $6.5M | — | New |
| 3 | Simplify Asset Management Inc. | 1.2M | $3.5M | +0 (+0.0%) | No change |
| 4 | LPL Financial LLC | 728.4K | $2.1M | +95.3K (+15.1%) | Added |
| 5 | KVP Capital Advisors, LP | 462.4K | $1.4M | +0 (+0.0%) | No change |
| 6 | BlackRock, Inc. | 439.4K | $1.3M | +20.2K (+4.8%) | Added |
| 7 | UBS Group AG | 326.3K | $959.2K | +41.0K (+14.4%) | Added |
| 8 | VANGUARD FIDUCIARY TRUST CO | 316.2K | $929.6K | — | New |
| 9 | JANE STREET GROUP, LLC | 176.6K | $519.2K | -205.6K (-53.8%) | Trimmed |
| 10 | Lakeside Advisors, INC. | 111.1K | $326.6K | — | New |
| 11 | WELLS FARGO & COMPANY/MN | 102.0K | $299.8K | +31.9K (+45.6%) | Added |
| 12 | Blue Trust, Inc. | 85.9K | $252.5K | +0 (+0.0%) | No change |
| 13 | Hudson Bay Capital Management LP | 84.9K | $249.6K | +17.2K (+25.5%) | Added |
| 14 | MANCHESTER FINANCIAL INC | 66.2K | $194.7K | +7.1K (+12.1%) | Added |
| 15 | DIMENSIONAL FUND ADVISORS LP | 52.4K | $154.1K | +0 (+0.0%) | No change |
| 16 | MEMBERS WEALTH LLC | 30.0K | $126.9K | +0 (+0.0%) | No change |
| 17 | Next Capital Management LLC | 35.0K | $102.9K | +18.9K (+117.0%) | Added |
| 18 | BCV Asset Management Inc. | 26.4K | $77.5K | — | New |
| 19 | Goldstone Financial Group, LLC | 24.2K | $71.0K | +0 (+0.0%) | No change |
| 20 | Vanguard Global Advisers, LLC | 22.6K | $66.5K | — | New |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once ACHV's latest filing finishes processing.